Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →
Wellinks Closed $10 Million Series B Funding from UMass Memorial Health and inside investors to accelerate growth and expand patient access.
PRIVATEAug 04, 2026•3 days ago
Amount Raised
$10 Million
Round Type
Series B
Investors
Inside InvestorsU Mass Memorial Health
Description
Wellinks, a leader in cardiopulmonary care, announced the first close of its Series B Funding, securing $10 million. The investment will fund commercial growth with participation from UMass Memorial Health and other inside investors. Wellinks aims to expand its predictive care solution through this funding. The collaboration with UMass Memorial reflects a commitment to advancing proactive, data-driven care.
Related People
Suggested for you
3 contactsVerified contactsStephanie, Vice President of Customer Success hidden hidden
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching Wellinks? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan